This Week’s Biopharma News: Big Moves in Bispecifics - Quiz - MDSpire

This Week’s Biopharma News: Big Moves in Bispecifics

Akeso’s PD-1/VEGF bispecific beats PD-1 plus chemo in lung cancer, Amgen wins EC approval for its DLL3-targeted T-cell engager, and Aragen scales Renaissance’s Fast Track anti-GD2 antibody

  • June 9, 2026

  • 5 min

Share

Original Source(s)

This Week’s Biopharma News: Big Moves in Bispecifics

  • June 9, 2026

Related Content

“Assessment of an EMR-integrated Onco-Insight hospital-based cancer registry system for data completeness and data entry turnaround time at a tertiary care cancer center in India”

Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study

A multi-task deep learning framework for simultaneous prediction of microsatellite instability and tumor mutational burden in gastric cancer from histopathological images